BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 2012
View Archived Issues
Amgen offers pipeline update for first quarter 2012
Read More
GSK reflects on achievements of first quarter 2012
Read More
U.K. study reveals new potential marker of acute kidney injury in acute on chronic liver failure
Read More
Promising candidate biomarker of venous thrombosis uncovered
Read More
Responses to sodium oxybate vary in phase I/II trial
Read More
FDA approves sNDA for Votrient
Read More
Afinitor approved in U.S. for new indication
Read More
Novel PLK1 inhibitor exhibits antitumor activity in vivo
Read More
Double-blind trial assesses extended-release once-daily epilepsy drug
Read More
Shionogi submits NDA for tablets to treat vulvar and vaginal atrophy
Read More
BioAlliance Pharma provides update on AMEP biotherapy
Read More
Repligen reports on RG-1068 NDA
Read More
Sanofi vaccine approved in Japan to prevent acute flaccid poliomyelitis
Read More
Orphan drug reverses vision loss in patients with Leber's hereditary optic neuropathy
Read More
Novel telomerase inhibitors developed at Pharminox
Read More
Almirall presents new SYK/JAK inhibitors
Read More
Proximagen designs novel chemokine CCR2 receptor antagonists
Read More
New monoamine reuptake inhibitors discovered in China
Read More
Kissei Pharmaceutical patents new indolizine derivatives
Read More
FDA approves new product to treat erectile dysfunction
Read More
Manhattan Pharmaceuticals to change name
Read More
Pivotal macitentan study meets primary endpoint
Read More
Athersys discusses development of cell therapy with FDA
Read More
Trimel gives update on special population study of male hypogonadism treatment
Read More
Algeta and Sanofi extend research collaboration
Read More